Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2013 ∙ Fischer Walker, C. L. Munos, M. K. Black, R. E.

Quantifying the indirect effects of key child survival interventions for pneumonia, diarrhoea, and measles

  • Newborn
  • Children
  • Malaria
  • Measles
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2013 ∙ Rafferty, E. Duclos, P. Yactayo, S. Schuster, M.

Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: A systematic review

  • Adults
  • Older adults
  • Travellers
  • Yellow fever
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2013 ∙ Schillie, S. F. Murphy, T. V.

Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review. (Special Issue: Human immune response to vaccines in the first year of life.)

  • Newborn
  • Hepatitis B
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2013 ∙ Nagata, J. M. Hernández-Ramos, I. Kurup, A. S. Albrecht, D. Vivas-Torrealba, C. Franco-Paredes, C.

Social determinants of health and seasonal influenza vaccination in adults

  • Older adults
  • Influenza
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2013 ∙ Cortés, I. Pérez-Camarero, S. del Llano, J. Peña, L. M. Hidalgo-Vega, Á

Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012

  • Europe
  • Spain
  • All age groups
  • Hepatitis A
  • Hepatitis B
  • Rotavirus
  • Influenza
  • Varicella
  • Tetanus
  • Measles
  • Human papillomavirus (HPV)
  • Streptococcus group B
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2013 ∙ García-Altés, A.

Systematic review of economic evaluation studies: Are vaccination programs efficient in Spain?

  • Europe
  • Spain
  • All age groups
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2013 ∙ De la Hoz-Restrepo, F. Castañeda-Orjuela, C. Paternina, A. Alvis-Guzman, N.

Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines

  • All age groups
  • Rotavirus
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2013 ∙ Bahia, L. Toscano, C. M. Takemoto, M. Auraujo, V.

Systematic review of pneumococcal disease costs and productivity loss studies in Latin America and the Caribbean

  • Americas
  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2013 ∙ Guo, B. A. Page, A. Wang, H. Q. Taylor, R. McIntyre, P.

Systematic review of reporting rates of adverse events following immunization: An international comparison of post-marketing surveillance programs with reference to China

  • Western Pacific
  • China
  • All age groups
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2013 ∙ Davis, S. Feikin, D. Johnson, H. L.

The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: A systematic review

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Haemophilus influenzae type B
  • Pneumococcal disease
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...